| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President &CEO
1 company
Struthers Richard Scott is a President &CEO at Crinetics Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 16 sells.
Estimated insider holdings value: $16.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 26, 2025 | CRNX Crinetics Pharmaceuticals, Inc. | President &CEO | Sell | 4,000 | $45.00 | $180,000.00 | -3.6% | +4.5% | - | |
| Mar 19, 2025 | CRNX Crinetics Pharmaceuticals, Inc. | President &CEO | Sell | 17,338 | $34.20 | $593,016.96 | -2.6% | -11.0% | +3.3% | |
| Dec 2, 2024 | CRNX Crinetics Pharmaceuticals, Inc. | President &CEO | Sell | 10,000 | $57.57 | $575,700.00 | -9.1% | -40.5% | -21.6% | |
| May 8, 2024 | CRNX Crinetics Pharmaceuticals, Inc. | President &CEO | Sale+OE | 107,448 | $49.40 | $5,307,931.20 | -29.4% | -1.4% | -35.7% | |
| Apr 4, 2024 | CRNX Crinetics Pharmaceuticals, Inc. | President &CEO | Sale+OE | 40,951 | $49.17 | $2,013,560.67 | -14.7% | -5.3% | -42.4% | |
| Nov 3, 2023 | CRNX Crinetics Pharmaceuticals, Inc. | President &CEO | Sale+OE | 200,000 | $30.56 | $6,111,440.02 | -42.5% | +21.2% | +84.7% | |
| Jul 13, 2023 | CRNX Crinetics Pharmaceuticals, Inc. | President &CEO | Sell | 50,000 | $20.21 | $1,010,316.74 | -2.5% | +32.6% | +162.1% | |
| Jun 16, 2023 | CRNX Crinetics Pharmaceuticals, Inc. | President &CEO | Sell | 50,000 | $20.81 | $1,040,500.00 | -6.8% | +44.1% | +123.1% | |
| Apr 13, 2022 | CRNX Crinetics Pharmaceuticals, Inc. | President &CEO | Sell | 138,643 | $26.83 | $3,719,625.48 | -5.5% | -26.4% | -40.2% | |
| Apr 5, 2022 | CRNX Crinetics Pharmaceuticals, Inc. | President &CEO | Sell | 21,357 | $25.34 | $541,224.82 | -2.4% | -17.9% | -34.2% |